negative

DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this…

2 weeks ago

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimers disease

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid pathology.The minimally…

3 months ago

KT&G Takes Legal Action Against Local Counterfeit Cigarette Manufacturers and Distributors in India

- Growing counterfeit cigarette manufacture and distribution leads to severe negative consequences for national credibility and regional economy SEOUL, South…

5 months ago